Park expands global sales network
Digital gamma camera developer Park Medical Systems is in theprocess of making several corporate-level moves designed to streamlinethe company's operations. Park has added to its global sales force, hiring sales reps tocover South Korea, China, Italy,
Digital gamma camera developer Park Medical Systems is in theprocess of making several corporate-level moves designed to streamlinethe company's operations.
Park has added to its global sales force, hiring sales reps tocover South Korea, China, Italy, the United Arab Emirates, Qatarand Austria. It has also restructured its North American offices,moving its U.S. office from Boston to Orlando and moving the officesof Toronto-based parent Park Meditech to those of Park Medicalin Montreal.
Park this month signed a sales and marketing agreement with cyclotrondeveloper CTI of Nashville, according to Richard Mullen, presidentand CEO of Park Medical and Park Meditech. CTI hopes that theuse of Park cameras in high-energy imaging will increase salesof fluorodeoxyglucose (FDG) manufactured in its cyclotrons.
New enhancements to Park's line of Smart digital cameras includeremote diagnostics, a learning mode for gantry motion, a scintimammographypositioning device and a new half-inch crystal option for high-energyimaging. Park will also show works-in-progress developments initerative reconstruction on Sun Microsystems' new Ultra 2 workstation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
